RNAZ · Transcode Therapeutics, Inc. · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“Due to the Company's recurring and expected continuing losses from operations, the Company has concluded there is substantial doubt concerning its ability to continue as a going concern for one year after the issuance of these consolidated financial statements without additional capital becoming available.”View the 10-Q filed Aug 14, 2026
Every disclosed holder of RNAZ in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns RNAZ
13F quarter Sep 30, 2026, combined view: filers that have not filed yet carry their Jun 30, 2026 positionsNo chart: the summed disclosures exceed shares outstanding, so they are not parts of one whole.
| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 33,512 | 0.20% |
| Insiders (Forms 3, 4, 5) | 14,134,481 | 83.48% |
| 13D/G-only blocks | 14,885,888 | 87.92% |
| Remaining | 12,123,142 | -71.60% |
| Registered funds (N-PORT, not summed) | 16,727 | 0.10% |
Shares outstanding: 16,930,739, the issuer's latest cover-page count restated onto today's split basis.
Remaining is negative: the summed disclosures exceed shares outstanding, as when filings are dated at different times or holders that do not disclose their links count the same shares. It is flagged, not clipped.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of RNAZ
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
CK Life Sciences Int'l., (Holdings) Inc.
13D
CIK 1297567 · Holding company · Aug 3, 2026
|
14,134,481 | ||
| 2 |
|
14,134,481 | ||
| 3 |
Unleash Immuno Oncolytics, Inc.
13G
CIK 1732374 · Unknown · Jul 23, 2026
Rule 13d-1(c), passive investor
|
300,000 | ||
| 4 |
|
186,236 | ||
| 5 |
|
155,611 | ||
| 6 |
|
101,772 | ||
| 7 |
Yorkville Advisors Global, LP
13F
CIK 1838613 · Registered investment adviser · Jun 30, 2026
carried, not yet filed for the newest quarter
|
19,639 | ||
| 8 |
VANGUARD CAPITAL MANAGEMENT LLC
13F
CIK 2100119 · Registered investment adviser · Jun 30, 2026
carried, not yet filed for the newest quarter
|
6,545 | ||
| 9 |
VANGUARD EXTENDED MARKET INDEX FUND
Fund
S000002841 · Registered fund · Jun 30, 2026
VANGUARD INDEX FUNDS, not summed
|
6,545 | ||
| 10 |
Anson Funds Management LP
13G
CIK 1491072 · Registered investment adviser · Dec 31, 2024
Rule 13d-1(b), qualified institution
|
4,053 | ||
| 11 |
VANGUARD FIDUCIARY TRUST CO
13F
CIK 933478 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
|
2,982 | ||
| 12 |
|
2,888 | ||
| 13 |
|
2,484 | ||
| 14 |
Thomas Joseph Tracy
13D
CIK 2062715 · Mar 7, 2025
|
1,250 | ||
| 15 |
FMR LLC
13F
CIK 315066 · Holding company · Jun 30, 2026
carried, not yet filed for the newest quarter
|
706 | ||
| 15.1 |
Fidelity Extended Market Index Fund
Fund
S000006021 · Registered fund · May 31, 2026
Fidelity Concord Street Trust, not summed
|
8,492 | ||
| 15.2 |
Fidelity Series Total Market Index Fund
Fund
S000065248 · Registered fund · May 31, 2026
Fidelity Concord Street Trust, not summed
|
1,180 | ||
| 15.3 |
Fidelity Total Market Index Fund
Fund
S000006026 · Registered fund · May 31, 2026
Fidelity Concord Street Trust, not summed
|
510 | ||
| 16 |
Tower Research Capital LLC (TRC)
13F
CIK 1533421 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
|
677 | ||
| 17 |
WELLS FARGO & COMPANY/MN
13F
CIK 72971 · Bank · Jun 30, 2026
carried, not yet filed for the newest quarter
|
55 | ||
| 18 |
SBI Securities Co., Ltd.
13F
CIK 1851815 · Unknown · Jun 30, 2026
carried, not yet filed for the newest quarter
|
12 | ||
| 19 |
IFP Advisors, Inc
13F
CIK 1641866 · Registered investment adviser · Sep 30, 2026
|
8 | ||
| 20 |
|
1 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.